P Azoyan, R Garnier, F J Baud, M L Efthymiou
Index: Therapie. 45(2) , 139-44, (1990)
Full Text: HTML
Toloxatone is a new monoamine oxidase inhibitor. One hundred and twenty two cases of poisoning with this drug are reported. In this series, the minimal toxic dose was 2 g. The first symptoms appeared about one hour after ingestion. In most cases, only drowsiness and mild adrenergic effects were observed. In a few cases of massive overdose, coma, pyramidal irritation, and myoclonic jerks occurred. In 3 cases of severe poisoning, toloxatone was associated with tricyclic antidepressants. Symptoms were similar to those reported in intoxications associating classical monoamine oxidase inhibitors and tricyclic antidepressants: muscular rigidity, hyperthermia and cardiovascular collapse. Two of these patients died.
| Structure | Name/CAS No. | Molecular Formula | Articles |
|---|---|---|---|
![]() |
Toloxatone
CAS:29218-27-7 |
C11H13NO3 |
|
5-(2-Aminopropyl)indole (5-IT): a psychoactive substance use...
2014-01-01 [Drug Test. Anal. 6(7-8) , 607-13, (2014)] |
|
Comparison of Monoamine Oxidase Inhibitors in Decreasing Pro...
2015-05-01 [J. Pharmacol. Exp. Ther. 356 , 483-92, (2016)] |
|
A double-blind comparison of moclobemide and toloxatone in o...
1992-01-01 [Psychopharmacology 106 Suppl , S118-9, (1992)] |
|
Minor and clinically non-significant interaction between tol...
1993-01-01 [Eur. J. Clin. Pharmacol. 44(1) , 97-9, (1993)] |
|
Effect of acute ethanol administration on toloxatone pharmac...
1999-05-01 [Alcohol. Clin. Exp. Res. 23(5) , 885-90, (1999)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2026 ChemSrc All Rights Reserved
